Cryoport (NASDAQ:CYRX – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.42) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.09), Zacks reports. Cryoport had a negative net margin of 70.08% and a negative return on equity of 13.35%. Cryoport updated its FY 2025 guidance to EPS.
Cryoport Stock Performance
NASDAQ:CYRX traded up $0.26 during mid-day trading on Tuesday, hitting $5.06. 962,827 shares of the stock were exchanged, compared to its average volume of 285,872. The firm’s 50-day simple moving average is $7.39 and its 200 day simple moving average is $7.65. The stock has a market capitalization of $250.12 million, a price-to-earnings ratio of -1.50 and a beta of 1.59. Cryoport has a fifty-two week low of $4.58 and a fifty-two week high of $20.10. The company has a debt-to-equity ratio of 0.48, a quick ratio of 5.32 and a current ratio of 5.70.
Wall Street Analyst Weigh In
A number of research firms recently commented on CYRX. Needham & Company LLC reiterated a “buy” rating and set a $11.00 price target on shares of Cryoport in a report on Friday, January 17th. Guggenheim initiated coverage on Cryoport in a research note on Thursday, December 19th. They set a “buy” rating and a $11.00 target price for the company. Finally, Roth Mkm dropped their price target on Cryoport from $18.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, Cryoport presently has a consensus rating of “Moderate Buy” and a consensus price target of $12.29.
Cryoport Company Profile
Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.
Featured Stories
- Five stocks we like better than Cryoport
- What is diluted earnings per share (Diluted EPS)?
- GitLab: Get In While It’s Down—Big Rebound Ahead
- What is the Australian Securities Exchange (ASX)
- Tesla Stock: Finding a Bottom May Take Time
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Receive News & Ratings for Cryoport Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cryoport and related companies with MarketBeat.com's FREE daily email newsletter.